TL;DR
This study introduces "Easy Heights," a smartphone-based virtual reality (VR) app designed to treat acrophobia (fear of heights). They found that repeated use of the app significantly reduced avoidance behavior and subjective fear in real-life height situations, offering a promising, accessible, and low-threshold treatment option.
What Problem Does This Paper Address?
Fear of heights is a prevalent issue, affecting a significant portion of the population and often leading to functional impairment in daily life. While effective treatments like in-vivo exposure therapy exist, their uptake is limited due to factors such as patient willingness to confront feared stimuli, therapist reservations, and the time-intensive nature of preparation and conduction. Virtual reality (VR) exposure therapy has shown promise in overcoming some of these barriers, offering a controlled and flexible environment for exposure. However, VR treatment has largely remained confined to laboratory settings due to the cost and complexity of equipment. This paper addresses the need for a more accessible and scalable solution by developing and testing a stand-alone, smartphone-based VR exposure app that can be used outside of clinical settings.
Methods
The researchers conducted a single-blind, parallel-group, randomized controlled trial. They developed "Easy Heights," a VR app that utilizes a graduated behavioral exposure approach without cognitive interventions. The app simulates various height scenarios (rural mountain, cloudy weather, urban town) with multiple height levels, allowing users to progress based on their self-reported distress levels (SUDS).
The study involved two phases:
- Phase 1 (Acute Use): Participants with fear of heights (aged 18-60) used the Easy Heights app for a single 1-hour session. They were compared to a control group using a fear-unrelated VR task.
- Phase 2 (Repeated Use): Participants from Phase 1 who were eligible engaged in a home-based treatment regimen, using the Easy Heights app for six 30-minute sessions over two weeks. This was compared to a control group receiving no further intervention.
The primary outcome measure was performance in a real-life Behavioral Avoidance Test (BAT) on a lookout tower, considered an objective measure of fear. Secondary outcomes included subjective fear on the tower during the BAT and various fear-of-heights questionnaires (AQ, ATHQ, AES, DES).
Datasets
Not discussed in the paper. The study utilized a custom-developed VR app ("Easy Heights") and standard questionnaires for data collection.
Key Insights and Ideas
- Smartphone VR as a viable therapeutic tool: The study demonstrates that a readily accessible smartphone VR app can be as effective as more traditional or lab-based VR interventions for treating acrophobia. This significantly lowers the barrier to entry for both patients and potentially therapists.
- Effectiveness of pure exposure: The "Easy Heights" app focuses solely on exposure, without cognitive restructuring. The positive results suggest that for some individuals, direct exposure to feared stimuli in a controlled VR environment is sufficient for significant fear reduction.
- Transfer to real-life situations: Crucially, the study measured outcomes in a real-life BAT, confirming that the VR-induced fear reduction translates to actual behavioral changes in feared situations. This is a critical step beyond purely self-reported improvements.
- Acceptance and usability: High uptake and continuation rates in both phases indicate that the app was well-accepted by participants, suggesting good usability and a positive user experience.
Key Results
- Phase 1 (Acute Use): After a single 1-hour session, the Easy Heights group did not show significantly higher BAT scores compared to the control group. However, they did report beneficial effects on two secondary outcomes: the Acrophobia Questionnaire (AQ) and self-reported change of fear of heights.
- Phase 2 (Repeated Use): After the repeated home-based intervention, the Easy Heights group showed significantly higher BAT scores (Cohen's d = 1.3, p = 0.0001) compared to the control group. This indicates a substantial reduction in avoidance behavior.
- Significant improvements were also observed in secondary outcomes, including mean subjective fear on the tower during the BAT (Cohen's d = 1.3, p = 0.0001), AQ (Cohen's d = 1.25, p = 0.0002), and ATHQ (Cohen's d = 1.3, p = 0.0002).
- The intervention effects were largely independent of sex, age, diagnosis, and baseline values.
- Simulation sickness scores were slightly higher in the intervention group but remained very low.
Limitations and Future Work
- Selection Bias: The study recruited participants specifically for a smartphone-based intervention, potentially leading to a selection bias towards individuals already comfortable with technology. The generalizability to the broader population with fear of heights is therefore uncertain.
- Geographic and Language Limitations: The study was conducted in German-speaking Switzerland, limiting generalizability to other linguistic and cultural groups.
- Follow-up Period: The assessment was conducted 3-5 weeks after the last app use, and longer-term follow-up data were not collected.
- Dose-Response: The intervention duration and regime were predefined and not compared to other dosages, leaving the optimal dose-response relationship unexplored.
- Clinical Practice Translation: The study did not assess how well the results translate to clinical practice or how the app would be accepted in a blended treatment approach.
Future work could involve longer follow-up periods, exploring optimal intervention dosages, and investigating the app's integration into clinical settings and its effectiveness in diverse populations. The authors also plan to adapt the app for current VR systems and make it available in English at no cost.
Summary updated